350797-51-2 Usage
Chemical class
Indoline derivative
Molecular structure
A benzoyloxypropyl group attached to the nitrogen atom of the indoline ring
Salt form
Hydrochloride
Purpose of salt form
To increase solubility in aqueous solutions
Application
Commonly used in pharmaceutical research and development
Laboratory use
Easier to work with due to increased solubility
Potential applications
Development of new drugs for various medical conditions
Value
A valuable tool for scientists and researchers in the pharmaceutical industry
These properties and contents provide a brief overview of 1-(3-benzoyloxypropyl) Indoline hydrochloride, highlighting its structure, applications, and importance in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 350797-51-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,0,7,9 and 7 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 350797-51:
(8*3)+(7*5)+(6*0)+(5*7)+(4*9)+(3*7)+(2*5)+(1*1)=162
162 % 10 = 2
So 350797-51-2 is a valid CAS Registry Number.
350797-51-2Relevant articles and documents
METHOD FOR PREPARING SILODOSIN
-
Page/Page column 16; 17, (2013/05/09)
The present invention relates to a process for preparing silodosin with high optical purity up to 99.9% enantiomeric excess (e.e.) or above. The process makes use of a method step, in which the enantiomers contained in a racemic mixture of a compound represented by the general formula V: wherein * denotes the asymmetric center, R1 is a protecting group, and R2 is cyano or carbamoyl, are separated.
PROCESS FOR PREPARING AN INTERMEDIATE FOR SILODOSIN
-
Page/Page column 17, (2011/10/31)
The present invention provides a process for preparing a compound of formula (I), wherein R1 is a hydroxyl-protecting group and R2 is a cyano group or a carbamoyl group, wherein the process comprises the direct hydrogenation of the corresponding achiral nitro compound and the resolution of the racemic amino compound. The compound of formula (I) can easily be further transferred to silodosin.